Dermata Therapeutics Inc. (NASDAQ: DRMA)
$1.0900
+0.0100 ( -4.39% ) 971.2K
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Market Data
Open
$1.0900
Previous close
$1.0800
Volume
971.2K
Market cap
$2.22M
Day range
$1.0750 - $1.2740
52 week range
$1.0000 - $13.3500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Nov 14, 2024 |
10-q | Quarterly Reports | 47 | Nov 13, 2024 |
8-k | 8K-related | 22 | Sep 17, 2024 |
10-q | Quarterly Reports | 48 | Aug 07, 2024 |
8-k | 8K-related | 18 | Aug 07, 2024 |
8-k | 8K-related | 18 | Aug 02, 2024 |
8-k | 8K-related | 19 | Jun 07, 2024 |
8-k | 8K-related | 15 | Jun 05, 2024 |
8-k | 8K-related | 15 | May 24, 2024 |
8-k | 8K-related | 19 | May 17, 2024 |